Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

NowRx Announces Series B CrowdFunding Round on SeedInvest

On-demand pharmacy experienced tremendous growth following series A round; continues expansion to new markets, disrupting $330bn industry


News provided by

NowRx

Sep 30, 2019, 11:00 ET

Share this article

Share toX

Share this article

Share toX


MOUNTAIN VIEW, Calif., Sept. 30, 2019 /PRNewswire-PRWeb/ -- NowRx, the on-demand, free same-day delivery pharmacy that is disrupting the healthcare industry by reinventing pharmacy from the ground up, today announced a third crowdfunding round on SeedInvest, receiving over $500K in reservations in its first 24 hours, one of the fastest ramp-ups in SeedInvest's history. The company is raising $20 million on a pre-money valuation of $65 million.

The NowRx model solves all the pain points in the traditional pharmacy process: its proprietary software automation, robotics, logistics and AI enable same-day, free delivery of all prescription medications, saving consumers, to date, hundreds of thousands of wasted hours previously spent waiting in pharmacy lines, while also creating new efficiencies that remove millions of dollars in excess costs from the pharmacy process.

There is plenty of buzz around the need to improve the $330bn pharmacy space, but no one has used technology to solve all the pharmacy pain points the way NowRx has

Post this

The funding round, which has been qualified by the SEC, follows last year's $7 million Series A funding round, which was the largest healthcare crowdfunding round ever at SeedInvest.com. The pharmacy space, one of the few traditional industries that has not yet been disrupted via technology, has seen over $470 million dollars raised in the last year.

"We have carefully developed and proved our disruptive on-demand model. With just our first pharmacy facility we have experienced amazing growth: 2018 revenue was $4.7M, up 90% year over year and, based on July 2019 revenue, our annualized run rate is $7.4M – and we are taking our proven concept into new markets," said Cary Breese, CEO of NowRx.

With dramatically rising customer demand, NowRx recently expanded from its flagship base in Mountain View to San Jose, with other California cities scheduled in the months to come, including Orange County in October. The new funding round will further accelerate NowRx's expansion across California in 2019 and nationally in 2020.

"There is plenty of buzz around the need to improve the $330bn pharmacy space, but no one has used technology to solve all the pharmacy pain points the way NowRx has," continued Breese.

"Unlike mail-based services that keep consumers waiting for their medications - and are not ideal for delivering medications that need special care (refrigeration, narcotics, urgent, etc.) - NowRx's fleet of eco-friendly electric cars, own drivers, mobile app and its automated pharmacy fulfillment centers, enable rapid, free, same-day, hand delivery of all medications right to the customer's door, while connection to a pharmacist for consultation is just a click away."

To date, NowRx has filled over 100,000 prescriptions, served more than 18,000 customers, and has received prescriptions from more than 4,500 prescribing physicians, just in the Silicon Valley area. Each NowRx facility has prescription fulfillment capability equal to over 10 traditional pharmacies and robotics-driven advanced pharma-technology that can fill a prescription every 30 seconds.

A fully-licensed pharmacy, NowRx has received multiple industry certifications putting it well along the road to achieving critical mass, including from Surescripts to handle ePrescriptions on their nationwide network of 1.8 million physicians; from the DEA to handle Controlled Prescriptions electronically, and from Caremark for insurance claims. The company is also implementing the telecommunication standard for insurance processing which enables NowRx to handle all Commercial and Medicare claims.

"It's time the pharmacy process entered the on-demand economy. No one stands in line at the bank, no one waits for taxis anymore, but people still stand in line at the pharmacy surrounded by sick people waiting for their prescriptions," continued Breese. "NowRx solves that and more, by using cutting-edge technology and logistics to dramatically cut the onerous overhead costs of traditional pharmacies, enabling us to absorb delivery costs so the customer doesn't have to. The proof is in the consumer response: nearly 90% of our customers say they will use us again."

Click here for a video about NowRx and footage of pharma-efficiency fulfillment technology at work.

Download the NowRx app for iOS devices or for Android devices here.

Reg A+ Equity CrowdFunding (J.O.B.S. Act)

NowRx is offering securities through the use of an Offering Statement that has been qualified by the Securities and Exchange Commission under Tier II of Regulation A. A copy of the Final Offering Circular that forms a part of the Offering Statement may be obtained from: https://www.nowrx.com/nowrx-offering-circular-series-b-preferred-pdf

This Company's profile and accompanying offering materials may contain forward-looking statements and information relating to, among other things, the Company, its business plan and strategy, and its industry. These statements reflect management's current views with respect to future events based information currently available and are subject to risks and uncertainties that could cause the Company's actual results to differ materially. Investors are cautioned not to place undue reliance on these forward-looking statements as they are meant for illustrative purposes and they do not represent guarantees of future results, levels of activity, performance, or achievements, all of which cannot be made. The company does not undertake any obligation to revise or update these forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.

About NowRx
NowRx is an on-demand pharmacy, founded with the goal of developing software, artificial intelligence, robotics, and logistics to create the most convenient retail pharmacy service available, focused on free same-day delivery for prescription and OTC medications, thereby eliminating the need to visit a pharmacy. Dedicated to promoting better health and wellness through a quicker, easier, more reliable way to access – and adhere to - prescription medications, NowRx hand-delivers all available prescription medications door-to-door, on the same day, through its fleet of friendly, trained drivers. Using NowRx's proprietary pharma-efficiency technology, NowRx's team of pharmacists fill prescriptions at its locally-based, state-of-the-art, and fully-licensed pharmacies. With NowRx, consumers can reach their pharmacist on the second ring or instantly through video chat and will never, ever waste time in pharmacy waiting lines again. Learn more at http://www.nowrx.com

NowRx Media Contacts:
Angela Jacobson, angela(at)mwebbcom(dot)com, 714.454.8776
Crystal Hartwell, crystal(at)mwebbcom(dot)com, 714.987.1016

SOURCE NowRx

Modal title

NowRX Robotic arm
NowRX Robotic arm
NowRx delivery car
NowRx delivery car
NowRX Robotic arm NowRx delivery car

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.